Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Roche Holdings Ltd ADR (RHHBY)

Roche Holdings Ltd ADR (RHHBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 235,635,008
  • Shares Outstanding, K 6,830,000
  • Annual Sales, $ 67,325 M
  • Annual Income, $ 12,808 M
  • EBIT $ 0 M
  • EBITDA $ 21,007 M
  • 60-Month Beta 0.41
  • Price/Sales N/A
  • Price/Cash Flow 11.02
  • Price/Book 6.93
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/01/24
  • Annual Dividend & Yield 0.85 (2.46%)
  • Most Recent Dividend 0.847 on 03/14/24
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.1030 +1.16%
on 12/19/24
36.7400 -6.10%
on 12/09/24
-0.6300 (-1.79%)
since 11/20/24
3-Month
34.1030 +1.16%
on 12/19/24
40.6700 -15.17%
on 10/25/24
-4.9500 (-12.55%)
since 09/20/24
52-Week
29.2000 +18.15%
on 05/02/24
42.4300 -18.69%
on 08/30/24
-0.5100 (-1.46%)
since 12/20/23

Most Recent Stories

More News
Roche's Prasinezumab Misses Goal in Parkinson's Disease Study

Roche RHHBY announced data from the phase IIb PADOVA study which evaluated its investigational monoclonal antibody, prasinezumab, for treating people with early-stage Parkinson’s disease.The double-blind...

CSTL : 27.53 (+1.62%)
PRTA : 15.22 (-4.93%)
RHHBY : 34.5000 (+0.76%)
SPRO : 0.9551 (-4.30%)
Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases

Roche RHHBY announced that the European Medicines Agency has approved a prefilled syringe (PFS) of the ophthalmology drug Vabysmo (faricimab).The regulatory body approved Vabysmo PFS for use in the treatment...

GILD : 92.57 (+1.62%)
REGN : 701.85 (-0.90%)
RHHBY : 34.5000 (+0.76%)
BMY : 57.33 (+1.83%)
Regeneron Down 15.5% Year to Date: How to Play the Stock?

Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 15.5% in the year so far compared with the industry’s decline of 6.3%.The stock has underperformed the sector and the S&P 500 Index during...

BAYRY : 4.9100 (-0.41%)
REGN : 701.85 (-0.90%)
RHHBY : 34.5000 (+0.76%)
SNY : 47.71 (+0.44%)
Healthcare Executives Embrace Generative AI to Boost Patient Outcomes

/CNW/ -- USA News Group News Commentary – The healthcare industry is in the midst of a significant shift, driven by advancements in artificial intelligence...

NVDA : 134.70 (+3.08%)
AVAI : 0.5600 (+1.80%)
RHHBY : 34.5000 (+0.76%)
TEM : 35.54 (+7.60%)
AMZN : 224.92 (+0.73%)
AI Healthcare Innovations: How They're Shaping the Future for Patients and Investors

/CNW/ -- USA News Group News Commentary – The potential for artificial intelligence (AI) in healthcare is exploding, with economists now predicting AI could...

AIDX.TO : 2.00 (-2.91%)
HWAIF : 1.4000 (-1.41%)
AVAI : 0.5600 (+1.80%)
TDOC : 9.44 (+5.24%)
WELL.TO : 7.10 (+1.14%)
RHHBY : 34.5000 (+0.76%)
BFLY : 3.09 (+4.04%)
Industry Survey Reveals Overwhelming Support for AI-Powered Healthcare

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The healthcare sector is undergoing a profound transformation, propelled by the rapid evolution of artificial...

TWST : 47.94 (+9.90%)
AVAI : 0.5600 (+1.80%)
ABSI : 2.99 (+2.40%)
RXRX : 6.03 (-0.99%)
MDAI : 1.8900 (+0.53%)
RHHBY : 34.5000 (+0.76%)
Pharma Stock Roundup: LLY's Zepbound Success, FDA Updates for MRK, JNJ

This week, Eli Lilly’s LLY popular obesity drug, Zepbound showed better weight loss than Novo Nordisk’s Wegovy in a head-to-head study. The FDA granted Breakthrough Therapy designation to Merck’s...

AZN : 65.35 (+1.41%)
JNJ : 144.47 (+0.62%)
MRK : 98.05 (-1.48%)
LLY : 767.76 (+1.35%)
RHHBY : 34.5000 (+0.76%)
The Intersection of AI, Medicine, and Stocks: A New Era of Opportunities

EQNX::TICKER_START (OTCQB:AVAI),(OTCQX:RHHBY),(NASDAQ:AMZN),(NASDAQ:MDAI),(NYSE:MDT) EQNX::TICKER_END

AVAI : 0.5600 (+1.80%)
MDAI : 1.8900 (+0.53%)
RHHBY : 34.5000 (+0.76%)
MDT : 81.03 (+1.30%)
AMZN : 224.92 (+0.73%)
The Future of Medicine: How AI Is Transforming Healthcare and Stock Markets

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – Artificial intelligence (AI) is rapidly reshaping the healthcare landscape, with experts suggesting...

AVAI : 0.5600 (+1.80%)
SYK : 364.60 (+2.09%)
RXRX : 6.03 (-0.99%)
RHHBY : 34.5000 (+0.76%)
TEM : 35.54 (+7.60%)
The Intersection of AI, Medicine, and Stocks: A New Era of Opportunities Issued on behalf of Avant Technologies Inc.

/CNW/ -- USA News Group News Commentary – Artificial intelligence (AI) is revolutionizing healthcare, offering solutions that could dramatically reduce...

AVAI : 0.5600 (+1.80%)
GEHC : 78.91 (+1.91%)
MDAI : 1.8900 (+0.53%)
MDT : 81.03 (+1.30%)
RHHBY : 34.5000 (+0.76%)
AMZN : 224.92 (+0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Basel, Switzerland-based Roche Holding Ltd. is a leading health care company focused on developing and commercializing innovative diagnostic and therapeutic products and services, which enable early detection and prevention of diseases as well as their treatment and monitoring. The company conducts its...

See More

Key Turning Points

3rd Resistance Point 35.0633
2nd Resistance Point 34.8667
1st Resistance Point 34.6833
Last Price 34.5000
1st Support Level 34.3033
2nd Support Level 34.1067
3rd Support Level 33.9233

See More

52-Week High 42.4300
Fibonacci 61.8% 37.3761
Fibonacci 50% 35.8150
Last Price 34.5000
Fibonacci 38.2% 34.2539
52-Week Low 29.2000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar